...
首页> 外文期刊>Journal of tissue engineering and regenerative medicine >Vascular beds maintain pancreatic tumour explants for ex vivo drug screening
【24h】

Vascular beds maintain pancreatic tumour explants for ex vivo drug screening

机译:血管床维持胰腺肿瘤外植体进行离体药物筛查

获取原文
获取原文并翻译 | 示例
           

摘要

Our understanding of cancer progression or response to therapies would benefit from benchtop, tissue-level assays that preserve the biology and anatomy of human tumours ex vivo. We present a methodology for maintaining patient tumour samples ex vivo for the purpose of drug testing in a clinical setting. The harvested tumour biopsy, excised from mice or patients, is integrated into a support tissue that includes stroma and vasculature. This support tissue preserves tumour histoarchitecture and relevant expression profiles, and tumour tissues cultured using this system display different sensitivities to chemotherapeutics compared with tumour explants with no supporting tissue. The methodology is more rapid than patient-derived xenograft models, easy to implement, and amenable to high-throughput assays, making it an attractive tool for in vitro drug screening or for the guidance of patient-specific chemotherapies.
机译:我们对癌症进展或对疗法反应的理解将受益于维护人肿瘤的生物学和解剖学的组织水平测定。 我们提出了一种在临床环境中维持患者肿瘤样品的方法,以便在临床环境中进行药物检测。 从小鼠或患者切除的收获的肿瘤活组织检查集成到包括基质和脉管系统的支撑组织中。 该支持组织保留肿瘤组织结构和相关的表达型材,并且使用该系统培养的肿瘤组织与没有支撑组织的肿瘤外植物相比,与化学治疗剂相比显示不同的敏感性。 该方法比患者衍生的异种移植型号更快,易于实施,并且适用于高通量测定,使其成为体外药物筛选的有吸引力的工具或用于患者特异性化学疗法的指导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号